MX9603864A - Uso de un inhibidor recombinante de erythrina caffra para la purificacion de serina proteasas. - Google Patents
Uso de un inhibidor recombinante de erythrina caffra para la purificacion de serina proteasas.Info
- Publication number
- MX9603864A MX9603864A MX9603864A MX9603864A MX9603864A MX 9603864 A MX9603864 A MX 9603864A MX 9603864 A MX9603864 A MX 9603864A MX 9603864 A MX9603864 A MX 9603864A MX 9603864 A MX9603864 A MX 9603864A
- Authority
- MX
- Mexico
- Prior art keywords
- inhibitor
- serine protease
- purifying
- serine proteases
- polypeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y10S435/815—Enzyme separation or purification by sorption
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un proceso para la purificacion de las serina proteasas de una mezcla de proteína, uniendo la serina proteasa a un polipéptido inmovilizado con la actividad de un inhibidor DE-3 de Erythrina caffra, eliminando los componentes sin unir de la mezcla de proteína, separando la serina proteasa del inhibidor y separa el inhibidor inmovilizado de la serina proteasa soluble y aislar la serina proteasa, el cual está caracterizada porque se utiliza un polipéptido como el polipéptido el cual es el producto de una expresion procariotica o eucariotica de un ácido nucleico exogeno. Este inhibidor se distingue por una actividad específica mejorada y es particularmente adecuado para la purificacion de activadores del plasminogeno, tales como los activadores de plasminogeno de tejido (t-PA y derivados).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4408939 | 1994-03-16 | ||
DE4424171A DE4424171A1 (de) | 1994-03-16 | 1994-07-08 | Verwendung von rekombinantem Inhibitor aus Erythrina caffra zur Reinigung von Serinproteasen |
PCT/EP1995/000926 WO1995025168A1 (de) | 1994-03-16 | 1995-03-13 | Verwendung von rekombinantem inhibitor aus erythrina caffra zur reinigung von serinproteasen |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9603864A true MX9603864A (es) | 1997-03-29 |
Family
ID=25934769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9603864A MX9603864A (es) | 1994-03-16 | 1995-03-13 | Uso de un inhibidor recombinante de erythrina caffra para la purificacion de serina proteasas. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5958722A (es) |
EP (1) | EP0750667B1 (es) |
JP (1) | JP2846961B2 (es) |
AT (1) | ATE174962T1 (es) |
AU (1) | AU691904B2 (es) |
CA (1) | CA2185436C (es) |
CZ (1) | CZ285502B6 (es) |
ES (1) | ES2128721T3 (es) |
IL (1) | IL112995A (es) |
MX (1) | MX9603864A (es) |
NO (1) | NO316704B1 (es) |
NZ (1) | NZ282790A (es) |
SK (1) | SK282430B6 (es) |
WO (1) | WO1995025168A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0112122B1 (en) * | 1982-12-14 | 1991-08-28 | South African Inventions Development Corporation | Plasminogen activator |
AU597908B2 (en) * | 1985-10-04 | 1990-06-14 | Implico B.V. | A protein reagent having the ability to bind tissue plasminogen activator in its two chain form and/or its single chain form |
-
1995
- 1995-03-13 ES ES95913095T patent/ES2128721T3/es not_active Expired - Lifetime
- 1995-03-13 JP JP7523832A patent/JP2846961B2/ja not_active Expired - Lifetime
- 1995-03-13 EP EP95913095A patent/EP0750667B1/de not_active Expired - Lifetime
- 1995-03-13 AU AU20693/95A patent/AU691904B2/en not_active Expired
- 1995-03-13 WO PCT/EP1995/000926 patent/WO1995025168A1/de active IP Right Grant
- 1995-03-13 AT AT95913095T patent/ATE174962T1/de not_active IP Right Cessation
- 1995-03-13 CZ CZ962529A patent/CZ285502B6/cs not_active IP Right Cessation
- 1995-03-13 MX MX9603864A patent/MX9603864A/es unknown
- 1995-03-13 CA CA002185436A patent/CA2185436C/en not_active Expired - Lifetime
- 1995-03-13 SK SK1142-96A patent/SK282430B6/sk not_active IP Right Cessation
- 1995-03-13 US US08/702,703 patent/US5958722A/en not_active Expired - Lifetime
- 1995-03-13 NZ NZ282790A patent/NZ282790A/xx not_active IP Right Cessation
- 1995-03-14 IL IL11299595A patent/IL112995A/en not_active IP Right Cessation
-
1996
- 1996-09-13 NO NO19963849A patent/NO316704B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2185436A1 (en) | 1995-09-21 |
CA2185436C (en) | 2000-08-01 |
AU2069395A (en) | 1995-10-03 |
IL112995A (en) | 2004-07-25 |
US5958722A (en) | 1999-09-28 |
EP0750667B1 (de) | 1998-12-23 |
NO316704B1 (no) | 2004-04-13 |
WO1995025168A1 (de) | 1995-09-21 |
IL112995A0 (en) | 1995-06-29 |
JP2846961B2 (ja) | 1999-01-13 |
CZ252996A3 (en) | 1996-11-13 |
SK114296A3 (en) | 1997-05-07 |
JPH09503395A (ja) | 1997-04-08 |
ES2128721T3 (es) | 1999-05-16 |
NO963849D0 (no) | 1996-09-13 |
CZ285502B6 (cs) | 1999-08-11 |
ATE174962T1 (de) | 1999-01-15 |
EP0750667A1 (de) | 1997-01-02 |
SK282430B6 (sk) | 2002-02-05 |
AU691904B2 (en) | 1998-05-28 |
NZ282790A (en) | 1997-08-22 |
NO963849L (no) | 1996-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koklitis et al. | Purification of recombinant human prostromelysin. Studies on heat activation to give high-M r and low-M r active forms, and a comparison of recombinant with natural stromelysin activities | |
Conner et al. | Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D | |
Váradi et al. | Kringle 5 of human plasminogen carries a benzamidine-binding site | |
US5191063A (en) | Production of biologically active polypeptides by treatment with an exogenous peptide sequence | |
Chatterjee et al. | Determination of Km and kcat for signal peptidase I using a full length secretory precursor, pro-OmpA-nuclease A | |
Stürzebecher et al. | Mapping of the catalytic site of CHO‐t‐PA and the t‐PA variant BM 06.022 by synthetic inhibitors and substrates | |
AU670571B2 (en) | A method of proteolytically cleaving proteins and the use of said method | |
US5393666A (en) | Method of activating prothrombin | |
MX9603864A (es) | Uso de un inhibidor recombinante de erythrina caffra para la purificacion de serina proteasas. | |
Gabrijelcic-Geiger et al. | Human-calpain: simple isolation from erythrocytes and characterization of autolysis fragments | |
TW257792B (es) | ||
Zhang et al. | Characterization of OhS1, an arginine/lysine amidase from the venom of king cobra (Ophiophagus hannah) | |
HK1060147A1 (en) | Mouse glucuronyl c5-epimerase, dna encoding the same and use thereof. | |
Unger et al. | The proteolytic activity and cleavage specificity of fibronectin-gelatinase and fibronectin-lamininase | |
Han et al. | Stability of protease Q against autolysis and in sodium dodecyl sulfate and urea solutions | |
IL117761A0 (en) | Inhibitor of the erythrina caffra type and its use to purify serine proteases | |
Lijnen et al. | Characterization of a chimaeric plasminogen activator obtained by insertion of the second kringle structure of tissue-type plasminogen activator (amino acids 173 through 262) between residues Asp130 and Ser139 of urokinase-type plasminogen activator | |
AU601420B2 (en) | Process for the production of plasminogen activators in procaryotes | |
KR970701774A (ko) | 세린 프로테아제의 정제를 위한 에리트리나 카프라 유래 재조합 억제인자의 용도(use of a recombinant inhibitor from erythrina caffra for purifying serine proteases) | |
EP0292326A3 (en) | Modified enzyme | |
Wnendt et al. | Construction and structure–activity relationships of chimeric prourokinase derivatives with intrinsic thrombin-inhibitory potential | |
Murthy et al. | Purification and characterization of a non-kallikrein arginine esterase from dog urine | |
DK91291A (da) | Promotor til anvendelse i aspergillus |